Medicine
Macrilen 60 mg/1817 mg oral solution
Macrilen 60 mg/1817 mg oral solution is a prescription medicine containing Macimorelin for oral use, marketed by Aeterna Zentaris, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store pouches under refrigeration at 2-8°C (36-46°F).
Key facts
- Active ingredient (INN)
- Macimorelin
- Brand
- Macrilen
- Strength
- 60 mg/1817 mg
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 1 pouch
- Marketing authorisation holder
- Aeterna Zentaris
- Manufacturer
- Aeterna Zentaris
- Origin register
- US FDA, United States
- Storage
- Store pouches under refrigeration at 2-8°C (36-46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V04CD06 Macimorelin
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 January 2018
- Identifiers
- DailyMed set ID aeb30f1a-4815-47ae-a2cb-b6b4e26372e1NDC 58844-130Application NDA205598
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 pouch in 1 carton / 60 mg in 1 pouch | 58844-130-01 | Aeterna Zentaris | 29 January 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Macimorelin
Clinical summary
Macimorelin is a growth hormone secretagogue receptor agonist indicated for the diagnosis of adult growth hormone deficiency (AGHD). It is available as oral solution. MedsAcross supplies Macimorelin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MacimorelinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Macrilen prescribing information (Aeterna Zentaris) · U.S. National Library of Medicine, DailyMed
- Ghryvelin (previously Macimorelin Aeterna Zentaris): European public assessment report (EPAR) · European Medicines Agency
Need Macrilen 60 mg/1817 mg oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.